Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Plos One|August 11, 2012
Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decadesNobuaki Ochi, Katsuyuki Hotta, Nagio Takigawa, et al.
Therapeutic Advances in Medical Oncology|January 29, 2024
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, et al.
Molecular Cancer Research : MCR|December 15, 2012
Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cellsDaisuke Minami, Nagio Takigawa, Hiromasa Takeda, et al.
Cancer Letters|July 12, 2011
Establishment of pemetrexed-resistant non-small cell lung cancer cell linesDan Zhang, Nobuaki Ochi, Nagio Takigawa, et al.
Onkologie|August 8, 2012
Favorable response of heavily treated Wilms' tumor to paclitaxel and carboplatinSaeko Ozaki, Nagio Takigawa, Eiki Ichihara, et al.
Cancer Research|August 20, 2009
Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic miceKadoaki Ohashi, Nagio Takigawa, Masahiro Osawa, et al.
Molecular Cancer Therapeutics|February 28, 2013
Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer modelTakashi Ninomiya, Nagio Takigawa, Eiki Ichihara, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2013
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelToshi Murakami, Nagio Takigawa, Takashi Ninomiya, et al.
Acta Medica Okayama|April 29, 2020
Association between Histological Types and Enhancement of Dynamic CT for Primary Lung CancerShogo Fukuma, Takayoshi Shinya, Junichi Soh, et al.
Cancer Science|September 17, 2013
Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer modelHiromi Hayakawa, Eiki Ichihara, Kadoaki Ohashi, et al.
Pageof 18